The Russian Health Ministry has abandoned a proposal to allocate additional funding to the fight against the spread of HIV. According to the RBC news agency, the ministry submitted a four-year plan to the federal government this week that does not include a proposal to ...

Around one in six young and middle-aged HIV-positive men doing well on antiretroviral therapy (ART) had low testosterone levels, French investigators report in the online edition of AIDS. Overall, 12% of the sample had low testosterone, or male hypogonadism. Risk factors were longer duration of ...

Gene therapy — which involves modifying genetic material, such as DNA and RNA — holds exciting potential as a cure for numerous diseases and conditions, including HIV. Timothy Brown (the “Berlin patient”) remains the only person known to have been cured of HIV. Brown received a ...

Initiating, rather than deferring, antiretroviral therapy (ART) reduces the risk of severe bacterial infections in HIV-positive individuals with high CD4 counts, researchers say. Their data are from the START trial, which showed a 57% reduction in the risk of AIDS and non-AIDS morbidity and mortality in ...

Conditional marketing authorisations give patients access to important new medicines earlier EMA publishes report with data collected between 2006 and June 2016 Conditional marketing authorisation (CMA) can speed up access to medicines for patients with unmet medical needs. Since 2006, a total of 30 medicines have received ...

Researchers in two new studies say they can leverage the body’s own antibodies to fight the virus that causes AIDS. In the field of HIV research, antibodies continue to be a targeted area. Two new studies published January 19 in Science Translational Medicine offer potential new treatment ...

Health Ministry says 824,000 of the estimated 850,000 HIV-positive people in Russia have already been added to the registry/ The Russian government has abandoned plans to fine HIV-infected patients who refuse to register on a Kremlin-administered list of sufferers. Patients would have been forced to add their name ...

Agonist therapy with methadone could use existing structure to reduce addiction, HIV Opioid agonist therapy using methadone is regarded as one of the most effective treatments for opioid use disorders as well as helping to reduce HIV risks. Such therapy, however, is not yet available in ...

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today (January 23) the initiation of the next human clinical trial of GeoVax’s preventive HIV vaccine, GOVX-B11. The Phase 1 trial (designated HVTN 114) is being conducted by the HIV Vaccine Trials Network ...

From the first days of annexation of Crimea and launch of the military operation in the east of Ukraine, Alliance for Public Health (hereinafter – Alliance) defined that one of its priorities was support of HIV, tuberculosis, viral hepatitis prevention and treatment programs, as well ...

For the past two years, Rachel King, PhD, MPH, an academic coordinator at UCSF Global Health Sciences, has been helping Ugandan parents and caregivers find developmentally appropriate ways to tell their children that the child has HIV. There are an estimated 150,000 HIV-infected children in Uganda, ...

Kaiser Family Foundation: The Global HIV/AIDS Epidemic This updated fact sheet provides information on current HIV prevalence and incidence, prevention and treatment strategies, and the U.S. and global responses to the epidemic (1/19). Kaiser Family Foundation: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) This updated fact ...

Long-term care for an aging HIV population is uncharted territory, as researchers and physicians are seeing the effects of the first wave of individuals who have been on antiretroviral therapy (ART) for a significant period of time. An increasing amount of academic and clinical research has ...

Providing pre-exposure prophylaxis (PrEP) to people who need it entails at least nine key steps, which can be conceived of as a PrEP continuum of care, according to an article published online ahead of print by Amy Nunn and colleagues in AIDS. This continuum can ...

Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, ...

DPP® HIV-Syphilis Assay on track for U.S. regulatory submission in 2017 MEDFORD, N.Y., Jan. 17, 2017 — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received a CE mark for its DPP® HIV-Syphilis combination assay. ...

Even in very early (acute) HIV infection—before fourth generation HIV test assays are able to detect an HIV infection—immune activation and inflammatory processes may already be occurring, new research shows. And, very early antiretroviral therapy (ART) may reduce, although not fully suppress, production of inflammatory markers ...

The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors’ practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention and even oncologists on Twitter, according to a ...